FuelCell Energy enters Thursday's earnings release down a third over the past month, with short sellers at their most aggressive positioning in the 30-day window and a cohort of new institutional buyers sitting on fresh losses.
The price collapse is the sharpest signal heading into the print. FCEL fell 15.7% on September 2 alone and has shed 33.4% over the past month, closing at $14.40. That move has arrived simultaneously with a short-interest rebuild that was already documented in the previous ORTEX note: SI has climbed to 37% of the free float, up 20.6% over the past week, with bears adding roughly three million shares between August 24 and September 1. The ORTEX short score has edged higher to 61.8 as of September 1, ranking in just the 6th percentile of free-float shorts — meaning the bet against FCEL is more heavily subscribed than 94% of stocks in the universe. Options traders are modestly more defensive too, with the put/call ratio at 0.46, slightly above its 20-day average of 0.43, though at just 1.2 standard deviations above the mean, the signal is cautionary rather than alarming.
The analyst community upgraded FCEL aggressively through June and July — UBS moved to Buy with a $27 target in mid-July, B. Riley upgraded to Buy with a $32 target in late June, and Jefferies and Canaccord also moved to Buy around the same time. The consensus mean target now runs at $20.86, still well above the current price. Wells Fargo remains the outlier, holding Underweight with an $8 target. The bull case rests on a $341.8 million cash cushion, service revenue growth of 135.5% sequentially, and a partnership with ExxonMobil that management expects to improve project economics. Bears point to persistent gross losses — $6.6 million in the most recent quarter, worse than the prior period — and declining advanced technology contract revenues, which fell 38.4% in the previous comparable period. With the stock now trading nearly 30% below the analyst consensus, either the Street has to cut or the print needs to be genuinely constructive to close the gap.
The ownership picture adds an interesting layer. BlackRock crossed the 5% threshold in its most recent 13G amendment filed July 28, lifting its stake from 2.1% to 6.2%. Alex Meruelo filed a fresh 13G in mid-July declaring a 4.6% position. Citadel Securities crossed 3.8% in a debut filing on August 4. These are passive or near-passive disclosures — no 13D activist is on the register — but the cluster of new filings from large and sophisticated buyers in July and August means several of them are now sitting on material mark-to-market losses given the subsequent price decline. That overhang matters: a weak print could prompt additional selling, while a strong one would test whether the thesis that drew them in still holds. Borrow availability remains comfortable at 210%, and cost to borrow is still just 0.38%, so there is no technical impediment to further short-building if sentiment deteriorates further. The print will test whether FCEL's revenue momentum is durable enough to justify the analyst upgrades — or whether the bears who spent August adding to their positions were simply earlier to the conclusion.
See the live data behind this article on ORTEX.
Open FCEL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
